louisakewell, Author at European Medical Journal - Page 88 of 153

EMJ

SCHILLER Enables the Export of ECG Raw Data: Resting ECGs, Exercise ECGs and Resting Rhythms

SCHILLER’s declared goal is to make therapy-relevant data accessible in digital form throughout the hospital. Thanks to the latest development, we have…

EMJ

International Guidelines for Detecting Prostate Cancer with MRI Scans

GLOBAL guidelines introducing a new standard for how MRI images are evaluated to diagnose prostate cancer promise to reduce the number of cases of…

EMJ

Effective Treatment of Urinary Infections Using DNA Sequencing

NOVEL DNA sequencing device has been identified as a potential tool to increase the speed and efficacy of the treatment of urinary tract infections (UTIs).

EMJ

Oncimmune Appoints Dr James Jett, World Recognised Lung Cancer Specialist, as Chief Medical Officer

Nottingham, UK – 19 November 2015: Oncimmune, a leader in early cancer detection, today announced the appointment of Dr James Jett, as Chief Medical…

EMJ

Safety and Efficacy Multicentre Study of a New Multifocal Treatment to Control Acne-Prone Skin

OBJECTIVE: Assess the effectiveness and safety of a new multifocal topical method (acnelan) for acne-prone skin, using in-vitro and in-vivo studies.

EMJ

Genomics England: 100,000 Genomes Project

Clare Turnbull, MD, PhD, gives an overview of her talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, where the Genomics…

EMJ

Reducing prostate cancer progression and mortality: what patients can do to reduce risk

Stacey Kenfield, DSc gives an overview of her talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference. Dr Kenfield talks about how…

EMJ

Helping healthcare professionals initiate conversations about physical activity

At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Justin Webb talks about the initiatives Macmillan Cancer Support is implementing…

EMJ

Two New Analyses Show Cost Effectiveness of Rifaximin-α 550mg Treatment in Belgian and Dutch Patients with Recurrent Hepatic Encephalopathy

LONDON, UK, Thursday 19 November, 07.00 GMT: Norgine B.V. has presented new analyses demonstrating the cost effectiveness of XIFAXAN® / TARGAXAN® 550…

EMJ

Keeping active with Macmillan Cancer Support

At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Justin Webb gives an overview of a new Macmillan Cancer Support initiative aimed…